三友医疗
(688085)
| 流通市值：63.01亿 | | | 总市值：66.96亿 |
| 流通股本：3.14亿 | | | 总股本：3.33亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 391,466,199 | 249,760,157.28 | 116,434,264.4 | 453,595,346.98 |
| 营业收入 | 391,466,199 | 249,760,157.28 | 116,434,264.4 | 453,595,346.98 |
| 二、营业总成本 | 320,403,798.47 | 211,662,677.74 | 98,103,543.87 | 422,864,287.61 |
| 营业成本 | 100,558,351.55 | 68,020,596.43 | 30,438,330.77 | 130,023,713.27 |
| 税金及附加 | 5,521,173.01 | 3,077,011.45 | 1,254,850.84 | 5,651,505.96 |
| 销售费用 | 124,631,323 | 78,387,511.07 | 35,806,440.3 | 144,542,711.05 |
| 管理费用 | 42,755,710.38 | 28,545,929.63 | 13,667,186.19 | 67,163,494.75 |
| 研发费用 | 55,683,139.15 | 37,520,482.42 | 18,097,373.58 | 84,288,436.24 |
| 财务费用 | -8,745,898.62 | -3,888,853.26 | -1,160,637.81 | -8,805,573.66 |
| 其中:利息费用 | 1,035,913.41 | 781,522.87 | - | 1,174,521.16 |
| 其中:利息收入 | 5,884,750.4 | 4,056,561.18 | - | 12,076,583.59 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -931.51 | -165,517.81 | -9,402.74 | 4,160,756.48 |
| 加:投资收益 | -1,945,887.39 | -267,527.43 | -403,057.16 | 1,520,728.42 |
| 资产处置收益 | -43,284.57 | -28,428.73 | -26,768.29 | 6,434,089.72 |
| 资产减值损失(新) | -11,964,912.05 | -7,618,536.04 | -3,381,767.74 | -26,127,694.17 |
| 信用减值损失(新) | -2,946,423.93 | -1,088,616.14 | -1,124,725.24 | -1,121,874.56 |
| 其他收益 | 8,789,129.86 | 8,213,157.85 | 1,032,372.97 | 5,468,906.68 |
| 四、营业利润 | 62,950,090.94 | 37,142,011.24 | 14,417,372.33 | 21,065,971.94 |
| 加:营业外收入 | 4,916,216.59 | 3,299,633.51 | 22,648.92 | 1,831,218.59 |
| 减:营业外支出 | 203,749.23 | 17,454.04 | 56,293.79 | 993,829.74 |
| 五、利润总额 | 67,662,558.3 | 40,424,190.71 | 14,383,727.46 | 21,903,360.79 |
| 减:所得税费用 | 13,545,149.93 | 8,554,797.54 | 3,790,867.71 | 9,790,634.14 |
| 六、净利润 | 54,117,408.37 | 31,869,393.17 | 10,592,859.75 | 12,112,726.65 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 54,117,408.37 | 31,869,393.17 | 10,592,859.75 | 12,112,726.65 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 61,981,265.41 | 36,600,784.63 | 12,823,438.55 | 11,468,618.1 |
| 少数股东损益 | -7,863,857.04 | -4,731,391.46 | -2,230,578.8 | 644,108.55 |
| 扣除非经常损益后的净利润 | 49,355,803.43 | 26,024,141.93 | 11,431,839.15 | -3,781,026.51 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.19 | 0.11 | 0.05 | 0.05 |
| (二)稀释每股收益 | 0.19 | 0.11 | 0.05 | 0.05 |
| 八、其他综合收益 | -2,203,981.14 | 2,551,222.72 | -84,241.52 | -849,901.15 |
| 归属于母公司股东的其他综合收益 | -1,641,203.03 | 2,972,309.54 | -62,810.48 | -624,653.22 |
| 九、综合收益总额 | 51,913,427.23 | 34,420,615.89 | 10,508,618.23 | 11,262,825.5 |
| 归属于母公司股东的综合收益总额 | 60,340,062.38 | 39,573,094.17 | 12,760,628.07 | 10,843,964.88 |
| 归属于少数股东的综合收益总额 | -8,426,635.15 | -5,152,478.28 | -2,252,009.84 | 418,860.62 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |